Dawna Smith
Family · Kansas City, KSNPI 1225660699
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 27.6% of the total. Reporting peaked in 2024 at $592 and has fallen 69.5% since, to $181 in 2025.
Across 67 payments — averaging $16.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$297
- Lilly USA, LLC$167
- AstraZeneca$101
- Amgen$75
- Novo Nordisk$74
- Abbott$46
- plus $314 from 14 others
What the payments were for
- Food & beverage$1,074100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $297 |
| Lilly USA, LLC | 9 | $167 |
| AstraZeneca | 6 | $101 |
| Amgen | 5 | $75 |
| Novo Nordisk | 4 | $74 |
| Abbott | 2 | $46 |
| Corium, LLC | 5 | $41 |
| Nevro Corp. | 2 | $35 |
| Merck | 2 | $28 |
| Sumitomo Pharma America, Inc. | 2 | $27 |
| Astellas Pharma US Inc | 1 | $24 |
| Phadia US Inc. | 1 | $24 |
| Idorsia Pharmaceuticals US Inc | 1 | $23 |
| Verrica Pharmaceuticals Inc. | 1 | $21 |
| GSK | 1 | $19 |
| Hologic Sales And Service, LLC | 1 | $15 |
| Boston Scientific | 1 | $15 |
| Exact Sciences | 1 | $14 |
| Pfizer | 1 | $14 |
| Axsome Therapeutics, Inc. | 1 | $13 |
How this compares
$1,074 in reported general payments places this provider in the 75th percentile of 1,579 family providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 62 | $589 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $358 |
| Losartan Potassium | 34 | $336 |
| Lisinopril | 32 | $324 |
| Duloxetine Hcl | 12 | $228 |
| Prednisone | 79 | $153 |
| Amlodipine Besylate | 30 | $145 |
| Atorvastatin Calcium | 23 | $133 |
| Mupirocin | 12 | $112 |
| Trazodone Hcl | 14 | $95 |
| Cephalexin | 16 | $93 |
| Pantoprazole Sodium | 12 | $68 |
| Cyclobenzaprine Hcl | 12 | $61 |
| Omeprazole | 11 | $51 |
| Azithromycin | 15 | $34 |
Paid to pharmacies, not to this prescriber.
Other family in Kansas City
- Zohra HussainiKansas City$329K
- Adam CaseKansas City$34K
- Kristina DelaneyKansas City$27K
- Amanda WilliamsKansas City$20K
- Mindy EldridgeKansas City$12K
- Liza RodriguezKansas City$11K
- Jhunne GalimbaKansas City$6K
- Graceann SandriKansas City$6K
- Jennifer ChesterOverland Park$327K
- Amanda CaldwellLeawood$203K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.